GABAeron, Inc.

GABAeron, Inc. is a biotech company in San Francisco, United States, founded in 2018. It has raised $1.8M across 4 rounds, most recently a $1.1M Grant in 2021 (est.).

Rebuilding Neurons, Restoring Lives

Employees
1–10
Founded
2018
Business Model
B2G
Total Funding
$1.8M
Last Round
$1.1M GrantJan 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

GABAeron is a San Francisco-based biopharmaceutical company developing iPSC-derived GABAergic interneuron cell therapies and small molecules to treat apoE4-linked neurodegenerative diseases, including Alzheimer's disease. The company combines precision medicine with regenerative medicine, targeting hippocampal neuron replacement as a first-in-class IND candidate.

Summary

It lists 1–10 employees. It has raised $1.8M in total across 4 rounds, most recently a $1.1M Grant round in 2021 (est.).

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II2021 (est.)
$1.1M

Sign up to see all 4 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GABAeron, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/gabaeron-inc"><img src="https://indexed.vc/api/badge/company/gabaeron-inc" alt="GABAeron, Inc. on Indexed.vc" width="260" height="76" /></a>